Cannabix Technologies (OTCMKTS:BLOZF) Trading Down 4.4% - Should You Sell?

Key Points

• Shares of Cannabix Technologies (OTCMKTS:BLOZF) fell 4.4% to $0.5376 on Thursday, trading as low as $0.5317 with about 91,060 shares changing hands, roughly 45% below average daily volume.
• The company has a market cap of $65.84 million and a negative PE of -26.88, while the 50‑day and 200‑day moving averages are $0.47 and $0.43, indicating it is currently unprofitable but trading near recent technical levels.
• Cannabix develops a handheld breathalyzer that uses proprietary sensor arrays and on‑board algorithms to rapidly detect recent THC use for law enforcement, public safety, and workplace testing.

Shares of Cannabix Technologies Inc. (OTCMKTS:BLOZF - Get Free Report) dropped 4.4% during trading on Thursday . The stock traded as low as $0.5317 and last traded at $0.5376. Approximately 91,060 shares were traded during trading, a decline of 45% from the average daily volume of 166,960 shares. The stock had previously closed at $0.5621.

Cannabix Technologies Trading Down 4.4%

The company has a market cap of $65.84 million, a PE ratio of -26.88 and a beta of 0.96. The business's 50 day moving average is $0.47 and its two-hundred day moving average is $0.43.

About Cannabix Technologies

Cannabix Technologies Inc is a Canada-based developer of bio­sensor technologies focused on the rapid, non-invasive detection of cannabis impairment. The company's flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, offering law enforcement agencies, public safety organizations and workplace safety departments a potential tool to assess impairment in real time.

The Cannabix breathalyzer employs proprietary sensor arrays and on-board algorithms to distinguish THC molecules in breath samples, delivering results without the need for laboratory analysis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.